AIP
WST icon

Arrowpoint Investment Partners’s West Pharmaceutical WST Stock Holding History

Arrowpoint Investment Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$32.8K – 1274
2024
Q4 		$32.8K Buy
+100
New +$31.5K 0.01% 715

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Arrowpoint Investment Partners's WST Position: Q4 2025 in Review

Arrowpoint Investment Partners sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 2,767 shares — an estimated $726K sold.

Arrowpoint Investment Partners first reported a position in WST in Q4 2024 and held it in 2 quarters. The position peaked at $726K in Q3 2025. 803 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Arrowpoint Investment Partners reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Arrowpoint Investment Partners sold 2,767 West Pharmaceutical shares in Q4 2025, an estimated $726K.
  • Arrowpoint Investment Partners first reported a position in West Pharmaceutical in Q4 2024 and held it in 2 quarters.
  • Arrowpoint Investment Partners's West Pharmaceutical position peaked at $726K in Q3 2025.
  • 803 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Arrowpoint Investment Partners's 13F filing for Q4 2025, filed 11 Feb 2026.